Eagle-eyed editor @natasharoy.bsky.social snagged this breaking news for today's Repro Roundup: The FDA is beginning its "safety review" of abortion drug mifepristone--a win for anti-abortion activists who are unhappy with telehealth abortion care & want more restrictions on prescribing the pill.
Plus, trans kids in New York sue to protect their health records from DOJ probe and Nevada minors can get an abortion without parental consent or a court order—for now.
